Guideline on treatment of neurocysticercosis: some observations

Simple item page
dc.contributor.authorBuerno De las casas, Jorge G
dc.contributor.authorCarpio Rodas, Luis Arturo
dc.contributor.authorVega Gama, Jose Gustavo
dc.contributor.authorRueda Franco, Fernando
dc.contributor.authorSethi, Nitin K
dc.contributor.authorWiebe, Sam
dc.contributor.authorHalperin, John J
dc.contributor.authorEscalaya, Alejandro L
dc.contributor.authorFleury, Agnes
dc.contributor.authorGarcia Pedroza, Felipe
dc.contributor.authorGonzález Duarte, Alejandra
dc.contributor.authorBaird, Ruth Ann
dc.contributor.authorZunt, Joseph R
dc.contributor.authorRoos, Karen L
dc.date.accessioned2020-05-21T23:49:48Z
dc.date.available2020-05-21T23:49:48Z
dc.date.issued2013
dc.descriptionBaird et al.[1] demonstrated that there are few evidence-based studies of antihelminthic treatment for neurocysticercosis (NC). This guideline has some limitations. The authors' procedure was to evaluate treatment based on the reduction of number of cysts. This method is misleading because if only one cyst out of many remains alive after treatment, it could prompt continued or recurrence of symptomsThe only valid criterion should be the disappearance of all viable parasites.[2] The authors' recommendation of albendazole treatment to reduce seizure frequency is questionable. The authors studied results that included patients with vesicular (live parasite) infections and patients with colloidal (degenerative/dead parasite) infections to evaluate treatment effect on seizures. It may be inaccurate to combine those studies because--considering the role of inflammation in …
dc.description.abstractBaird et al.[1] demonstrated that there are few evidence-based studies of antihelminthic treatment for neurocysticercosis (NC). This guideline has some limitations. The authors' procedure was to evaluate treatment based on the reduction of number of cysts. This method is misleading because if only one cyst out of many remains alive after treatment, it could prompt continued or recurrence of symptomsThe only valid criterion should be the disappearance of all viable parasites.[2] The authors' recommendation of albendazole treatment to reduce seizure frequency is questionable. The authors studied results that included patients with vesicular (live parasite) infections and patients with colloidal (degenerative/dead parasite) infections to evaluate treatment effect on seizures. It may be inaccurate to combine those studies because--considering the role of inflammation in …
dc.identifier.doi10.1212/WNL.0b013e3182a7afaf
dc.identifier.issn0028-3878, 1526-632X
dc.identifier.urihttp://n.neurology.org/content/guideline-treatment-neurocysticercosis-some-observations
dc.language.isoes_ES
dc.sourceNeurology
dc.subjectNeurocysticercosis
dc.titleGuideline on treatment of neurocysticercosis: some observations
dc.typeARTÍCULO
dc.ucuenca.afiliacionBuerno, J., The University of Western Ontario, London, Canada
dc.ucuenca.afiliacionCarpio, L., Universidad de Cuenca, Facultad de Ciencias Médicas, Cuenca, Ecuador
dc.ucuenca.afiliacionVega, J., Academia Mexicana de Neurología, AC, México, Mexico
dc.ucuenca.afiliacionRueda, F., Instituto Nacional de Pediatría, México, Mexico
dc.ucuenca.afiliacionSethi, N., Weill Cornell Medical College, New York, Estados unidos
dc.ucuenca.afiliacionWiebe, S., University of Calgary, Calgary, Canada
dc.ucuenca.afiliacionHalperin, J., Department of Neurosciences at Overlook Medical Center, Nueva Jersey, Estados unidos
dc.ucuenca.afiliacionEscalaya, A., Universidad Peruana Cayetano Heredia, Lima, Peru
dc.ucuenca.afiliacionFleury, A., Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
dc.ucuenca.afiliacionGarcia, F., Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
dc.ucuenca.afiliacionGonzález, A., Instituto Nacional de la Nutricion Salvador Zubiran, Tlalpan, Mexico
dc.ucuenca.afiliacionBaird, R., Indiana University School of Medicine, Indianapolis, Estados unidos
dc.ucuenca.afiliacionZunt, J., University of Washington, Seattle, Estados unidos
dc.ucuenca.afiliacionRoos, K., Indiana University School of Medicine, Indianapolis, Estados unidos
dc.ucuenca.areaconocimientofrascatiamplio3. Ciencias Médicas y de la Salud
dc.ucuenca.areaconocimientofrascatidetallado3.3.8 Parasitología
dc.ucuenca.areaconocimientofrascatiespecifico3.3 Ciencias de la Salud
dc.ucuenca.areaconocimientounescoamplio09 - Salud y Bienestar
dc.ucuenca.areaconocimientounescodetallado0914 - Tecnologías de Diagnóstico y Tratamiento Médico
dc.ucuenca.areaconocimientounescoespecifico091 - Salud
dc.ucuenca.cuartilQ1
dc.ucuenca.embargoend2050-05-21
dc.ucuenca.embargointerno2050-05-21
dc.ucuenca.factorimpacto3.5
dc.ucuenca.idautorSgrp-2141-1
dc.ucuenca.idautor0100737956
dc.ucuenca.idautorSgrp-2141-3
dc.ucuenca.idautorSgrp-2141-4
dc.ucuenca.idautorSgrp-2141-5
dc.ucuenca.idautorSgrp-2141-6
dc.ucuenca.idautorSgrp-2141-7
dc.ucuenca.idautorSgrp-2141-8
dc.ucuenca.idautorSgrp-2141-9
dc.ucuenca.idautorSgrp-2141-10
dc.ucuenca.idautorSgrp-2141-11
dc.ucuenca.idautorSgrp-2141-12
dc.ucuenca.idautorSgrp-2141-13
dc.ucuenca.idautorSgrp-2141-14
dc.ucuenca.indicebibliograficoSCOPUS
dc.ucuenca.numerocitaciones0
dc.ucuenca.urifuentehttps://n.neurology.org/
dc.ucuenca.versionVersión publicada
dc.ucuenca.volumenVolumen 81,. Número 16

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
documento.pdf
Size:
107.46 KB
Format:
Adobe Portable Document Format
Description:
document
Download

Collections

Artículos